Shanghai Model Organisms Center, Inc. (SHSE: 688265)
Health Care · Life Sciences Tools & Services · CN
CN¥60.93
-6.23% today · +30.4% 1Y
Shanghai Model Organisms Center, Inc. (SHSE: 688265) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $702.87M and employs 959 people.
Over the last twelve months the share price has gained 30.4%, trading between 30.36 and 65.56.
Tweenvest scores Shanghai Model Organisms Center, Inc. across four factors: quality 71/100, value 12/100, growth 77/100, dividend 43/100. Its strongest factor is growth.
688265 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $702.87M
- Revenue (TTM)
- $67.38M
- P/E
- 199.52
- EPS
- 0.31
- Dividend yield
- 0.21%
- Beta (5Y)
- 0.30
- 52-week high
- CN¥65.56
- 52-week low
- CN¥30.36
- Avg volume (3M)
- —
- Shares outstanding
- 77.27M
- Employees
- 959
- Next earnings
- —
About Shanghai Model Organisms Center, Inc.
Shanghai Model Organisms Center, Inc. (SMOC) is a prominent Chinese enterprise dedicated to the research and development of genetically engineered animal models. The company offers a broad spectrum of specialized rodent models, encompassing disease-specific, humanized, immunodeficient, tool, and fluorescent reporter strains of both mice and rats. Furthermore, SMOC produces custom cellular products, including fluorescently labeled, primary, and humanized cell lines. Beyond its core product offerings, SMOC delivers a comprehensive suite of support services. These include personalized model generation, animal husbandry and breeding programs, in-depth phenotypic analysis, and critical drug screening and evaluation services for preclinical research. Established in 2000, SMOC maintains its primary operations and corporate headquarters in Shanghai, China.
- ISIN
- CNE1000055L1
- Founded
- 2000
- Listed since
- Dec 28, 2021
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.SZSE: 301096 | $739.13M | CN¥45.65 | -7.40% |
| Pacific Biosciences of California, Inc.NasdaqGS: PACB | $724.24M | $2.14 | -8.37% |
| Mesa Laboratories, Inc.NasdaqGS: MLAB | $713.53M | $127.24 | -0.21% |
| Cytek Biosciences, Inc.NasdaqGS: CTKB | $705.81M | $5.24 | -3.59% |
| OmniAb, Inc.NasdaqGM: OABI | $696.42M | $4.80 | +0.21% |
| Gubra A/SCPSE: GUBRA | $696.24M | Dkr290.60 | +2.69% |
| Curiox Biosystems Co., LtdKOSDAQ: A445680 | $684.61M | ₩53,500.00 | -8.08% |
| Innova Captab LimitedNSEI: INNOVACAP | $656.33M | Rs1,110.00 | -4.97% |
Figures last refreshed Oct 11, 2026.